ContractAcer Therapeutics Inc. • November 9th, 2018 • Pharmaceutical preparations • Saint-Louis
Company FiledNovember 9th, 2018 Industry JurisdictionConfidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. Page 1 of 42 LICENSE AGREEMENT FOR DEVELOPMENT AND EXPLOITATION (“Agreement”) VAL No.2018/2016-305/2017-208/01 BETWEEN: The Assistance Publique – Hôpitaux de Paris, a public healthcare establishment whose registered office address is 3, Avenue Victoria, 75004 Paris, represented by its Chief Executive Officer, Mr Martin Hirsch, Represented by: Mrs Florence FAVRELFEUILLADE, Head of the Clinical Research and Innovation Delegation, Carré Historique de l’Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010 Paris in accordance with the CEO’s delegation order authorising her to sign this Agreement, hereinafter “AP-HP” AND ACER THERAPEUTICS INC. a Delaware, USA corporation having a place of business at One Gateway Center, Suite 351 (300 Washington Street) Newton, MA 02458 USA., and represented by Christopher Schelling, Founder and Chief Executive Offi